ArticleJournal of cannabis research2025

ABCB1 polymorphisms are associated with clinical response to nabiximols in patients with multiple sclerosis-related spasticity.

Alessandra Gemma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.